148 related articles for article (PubMed ID: 32314727)
61. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
[TBL] [Abstract][Full Text] [Related]
62. Parvovirus B19-associated purpuric-petechial eruption.
Hashimoto H; Yuno T
J Clin Virol; 2011 Nov; 52(3):269-71. PubMed ID: 21885329
[TBL] [Abstract][Full Text] [Related]
63. Parvovirus B19 Infection Is Associated with Autoimmune Thyroid Disease in Adults.
Heidari Z; Jami M
Int J Endocrinol Metab; 2021 Oct; 19(4):e115592. PubMed ID: 35069751
[TBL] [Abstract][Full Text] [Related]
64. Conformational changes in the VP1-unique region of native human parvovirus B19 lead to exposure of internal sequences that play a role in virus neutralization and infectivity.
Ros C; Gerber M; Kempf C
J Virol; 2006 Dec; 80(24):12017-24. PubMed ID: 17020940
[TBL] [Abstract][Full Text] [Related]
65. Acute parvovirus B19 infection in connection with a flare of systemic lupus erythematodes in a female patient.
Hemauer A; Beckenlehner K; Wolf H; Lang B; Modrow S
J Clin Virol; 1999 Sep; 14(1):73-7. PubMed ID: 10548133
[TBL] [Abstract][Full Text] [Related]
66. Systemic lupus erythematosus and parvovirus B-19: casual coincidence or causative culprit?
Severin MC; Levy Y; Shoenfeld Y
Clin Rev Allergy Immunol; 2003 Aug; 25(1):41-8. PubMed ID: 12794260
[TBL] [Abstract][Full Text] [Related]
67. Parvovirus infection mimicking systemic lupus erythematosus in a pediatric population.
Moore TL; Bandlamudi R; Alam SM; Nesher G
Semin Arthritis Rheum; 1999 Apr; 28(5):314-8. PubMed ID: 10342388
[TBL] [Abstract][Full Text] [Related]
68. Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin.
Ohtsuka T; Yamazaki S
Br J Dermatol; 2004 Jun; 150(6):1091-5. PubMed ID: 15214893
[TBL] [Abstract][Full Text] [Related]
69. Human parvovirus B19 in rheumatoid arthritis.
Takahashi Y; Murai C; Ishii T; Sugamura K; Sasaki T
Int Rev Immunol; 1998; 17(5-6):309-21. PubMed ID: 10036637
[TBL] [Abstract][Full Text] [Related]
70. The VP1 unique region of human parvovirus B19 and human bocavirus induce lung injury in naïve Balb/c mice.
Lin CY; Chung YH; Shi YF; Tzang BS; Hsu TC
PLoS One; 2018; 13(8):e0202667. PubMed ID: 30114253
[TBL] [Abstract][Full Text] [Related]
71. Antigenicity analysis of human parvovirus B19-VP1u protein in the induction of anti-phospholipid syndrome.
Lin CY; Chiu CC; Cheng J; Lin CY; Shi YF; Tsai CC; Tzang BS; Hsu TC
Virulence; 2018 Jan; 9(1):208-216. PubMed ID: 28960143
[TBL] [Abstract][Full Text] [Related]
72. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.
Antonelli A; Ferrari SM; Giuggioli D; Ferrannini E; Ferri C; Fallahi P
Autoimmun Rev; 2014 Mar; 13(3):272-80. PubMed ID: 24189283
[TBL] [Abstract][Full Text] [Related]
73. Parvovirus B19 infection after transplantation: a review of 98 cases.
Eid AJ; Brown RA; Patel R; Razonable RR
Clin Infect Dis; 2006 Jul; 43(1):40-8. PubMed ID: 16758416
[TBL] [Abstract][Full Text] [Related]
74. Human parvovirus B19 infection during the inactive stage of systemic lupus erythematosus.
Suzuki T; Saito S; Hirabayashi Y; Harigae H; Ishii T; Kodera T; Fujii H; Munakata Y; Sasaki T
Intern Med; 2003 Jun; 42(6):538-40. PubMed ID: 12857057
[TBL] [Abstract][Full Text] [Related]
75. Detection of IgE anti-parvovirus B19 and increased CD23+ B cells in parvovirus B19 infection: relation to Th2 cytokines.
Bluth MH; Norowitz KB; Chice S; Shah VN; Nowakowski M; Josephson AS; Durkin HG; Smith-Norowitz TA
Clin Immunol; 2003 Aug; 108(2):152-8. PubMed ID: 12921761
[TBL] [Abstract][Full Text] [Related]
76. Systemic lupus erythematosus associated with myasthenia gravis, pemphigus foliaceus and chronic thyroiditis after thymectomy.
Sawamura S; Kajihara I; Makino K; Makino T; Fukushima S; Jinnin M; Oyama B; Hashimoto T; Ihn H
Australas J Dermatol; 2017 Aug; 58(3):e120-e122. PubMed ID: 27270472
[TBL] [Abstract][Full Text] [Related]
77. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
[TBL] [Abstract][Full Text] [Related]
78. No serological indications that systemic lupus erythematosus is linked with exposure to human parvovirus B19.
Bengtsson A; Widell A; Elmstâhl S; Sturfelt G
Ann Rheum Dis; 2000 Jan; 59(1):64-6. PubMed ID: 10627430
[TBL] [Abstract][Full Text] [Related]
79. Antibodies to beta 2-glycoprotein I and cardiolipin with symptoms suggestive of systemic lupus erythematosus in parvovirus B19 infection.
Kalt M; Gertner E
J Rheumatol; 2001 Oct; 28(10):2335-6. PubMed ID: 11669178
[TBL] [Abstract][Full Text] [Related]
80. Pathophysiology and aetiological diagnosis of inflammatory myocardial diseases with a special focus on parvovirus B19.
Pankuweit S; Ruppert V; Eckhardt H; Strache D; Maisch B
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):344-7. PubMed ID: 16316398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
